Transcend Capital Advisors, LLC Amgen Inc Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 11,160 shares of AMGN stock, worth $2.95 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

11,160

Previous 11,107 0.48%

Holding current value

$2.95 Million

Previous $3.47 Million 3.6%

% of portfolio

0.25%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $16,397 - $17,881	53 Added 0.48%	11,160 $3.6 Million
Q2 2024 Jul 02, 2024	BUY	$262.75 - $319.31 $106,151 - $129,001	404 Added 3.77%	11,107 $3.47 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $54,311 - $65,561	202 Added 1.92%	10,703 $3.04 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $25,825 - $29,134	-101 Reduced 0.95%	10,501 $3.02 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $81,337 - $100,983	372 Added 3.64%	10,602 $2.85 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $18,427 - $21,789	-86 Reduced 0.83%	10,230 $2.27 Million
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $4,967 - $6,054	-22 Reduced 0.21%	10,316 $2.49 Million
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $6,870 - $8,730	30 Added 0.29%	10,338 $0
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $20,874 - $23,542	-93 Reduced 0.89%	10,308 $2.32 Million
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $113,970 - $126,829	-494 Reduced 4.53%	10,401 $2.53 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $156,339 - $172,952	713 Added 7.0%	10,895 $2.64 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $197,487 - $226,006	993 Added 10.81%	10,182 $2.29 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $49,034 - $57,449	-231 Reduced 2.45%	9,189 $1.92 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $68,438 - $75,928	293 Added 3.21%	9,420 $2.3 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $13,758 - $16,033	-62 Reduced 0.67%	9,127 $2.26 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $596,992 - $710,911	2,759 Added 42.91%	9,189 $2.11 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $1.51 Million - $1.68 Million	6,430 New	6,430 $1.63 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $1.43 Million - $1.75 Million	-7,210 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $54,672 - $72,510	300 Added 4.34%	7,210 $1.47 Million
Q4 2019 Feb 19, 2020	BUY	$189.21 - $243.2 $1.31 Million - $1.68 Million	6,910 New	6,910 $1.67 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Amgen Inc Transaction History